GUJARAT THEMIS BIOSYN
Back to Balance Sheet
|
GUJARAT THEMIS BIOSYN Last 5 Year Deferred Tax Assets / Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹1.96 Cr | ₹1.66 Cr | ₹1.30 Cr | ₹1.02 Cr | ₹0.98 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of GUJARAT THEMIS BIOSYN ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹1.96 Cr |
| Mar2024 | ₹1.66 Cr |
| Mar2023 | ₹1.30 Cr |
| Mar2022 | ₹1.02 Cr |
| Mar2021 | ₹0.98 Cr |
How is Deferred Tax Assets / Liabilities of GUJARAT THEMIS BIOSYN Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹1.96 Cr | 17.91 | |
| Mar2024 | ₹1.66 Cr | 28.00 | |
| Mar2023 | ₹1.30 Cr | 26.95 | |
| Mar2022 | ₹1.02 Cr | 4.60 | |
| Mar2021 | ₹0.98 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of GUJARAT THEMIS BIOSYN
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GUJARAT THEMIS BIOSYN | ₹3,789.4 Cr | -4% | 14.4% | 21.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹457,121.0 Cr | 3.2% | 12.5% | 10.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹181,396.0 Cr | 2.9% | 8.5% | 11.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹148,730.0 Cr | 0.3% | 5.7% | 36.3% | Stock Analytics | |
| CIPLA | ₹115,241.0 Cr | 10.4% | 15.9% | -5.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,126.0 Cr | 4.8% | 9% | 10.8% | Stock Analytics | |
GUJARAT THEMIS BIOSYN Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GUJARAT THEMIS BIOSYN | -4% |
14.4% |
21.1% |
| SENSEX | -0.9% |
-3.6% |
-8.6% |
You may also like the below Video Courses